Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Molecular Genetics and Metabolism|June 7, 2023
Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe RegistryLola E R Lessard, Céline Tard, Emmanuelle Salort-Campana, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2015
Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinomaMuhammad Ramzan, Nathalie Sturm, Thomas Decaens, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2025
HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotypeVincenzo Alfano, Giuseppe Rubens Pascucci, Giacomo Corleone, et al.
BMC Cancer|August 25, 2018
Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT)Kayvan Mohkam, Michel Rayar, Jean-Philippe Adam, et al.
Journal of Cancer|August 18, 2021
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal CancerSonia Brun, Jean-Marc Pascussi, Elena Patricia Gifu, et al.
Novartis Foundation Symposium|March 19, 2004
In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunityAlain P Vicari, Béatrice Vanbervliet, Catherine Massacrier, et al.
British Journal of Cancer|April 5, 2019
Sorafenib alone vs. sorafenib plus GEMOX as 1<sup>st</sup>-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trialEric Assenat, Georges-Philippe Pageaux, Simon Thézenas, et al.
Liver Cancer|July 9, 2021
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-AnalysisArndt Vogel, Lorenza Rimassa, Hui-Chan Sun, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2024
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinomaClémentine Alitti, Agnès Rode, Hervé Trillaud, et al.
Pageof 14